Aktiesnakken — Februar 2010
-
vi researcher....40.000 nhl patienter prisen er vist omkring 1/6
-
men det er fremtiden
-
masser af folk
-
undskyld halv pris
-
det lægger trods alt en del til potentialet hvis markedet er 40.000 patienter...også selv om det er til halv pris
-
bare de ikke skal lave hjemmesiden
-
der er ihvertfald INGEN analytikere der har emerging markets med i deres salgsforecast fra 2011
-
nu ved vi ikke hvormange cll patienter de har dernede og vi ved ikke hvad deres timeline er. Men jeg mener det hæver hele casen med 5-10%
-
så der er håb
-
godnat
-
aka, sidder du ned? 7 mio RA patienter i indien...
-
freaking hell.....de skal have den store hindu sprøjte
-
jeg tror nok de kører reditux i ra allerede
-
Reditux? is approximately priced at half the originator?s price. Product availability is planned at Company?s C&F agents and at all major ho
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind